Nobel Biocare Holding AG (NOBN)

Nobel Biocare Holding AG operates in the field of implant-based dental restorations worldwide. It offers dental implants for various indications, bone types, and surgical protocols under the NobelActive, Brånemark System, and NobelReplace brands; high-precision individualized prosthetics and CAD/CAM systems for every indication, from a single tooth to edentulous jaws, on natural teeth and implants under the NobelProcera brand; and machined and TiUnite implants. The company also provides a range of individualized CAD/CAM abutments and a portfolio of prefabricated temporary and final abutments; biomaterials for soft tissue and bone regeneration under the creos brand; and removable and fixed implant-supported restorations. In addition, it offers NobelClinician software for enhanced diagnostics and treatment planning; and NobelGuide, a treatment concept for diagnostics, prosthetic-driven treatment planning biomaterials and guided implant surgery. Nobel Biocare Holding AG provides training and education, as well as a range of practice support and patient information materials to its customers. The company markets its products to dental healthcare professionals comprising oral surgeons, general practitioners, specialists, and laboratories. Nobel Biocare Holding AG was founded in 1981 and is headquartered in Kloten, Switzerland. As of December 11, 2014, Nobel Biocare Holding AG operates as a subsidiary of Envista Holdings Corporation.